SCHEMBL7142283

SCHEMBL7142283

Cn1cccc1-c1nc2cc(C(=O)O)cc(N)n2n1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.43
ADORA2A P29274 16/20 0.42
NAMPT P43490 1/20 0.37
NPC1 O15118 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
NFKB1 P19838 1/20 0.36
HTT P42858 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6869047 0.87 ADORA2A (0.40) ADORA2ANAMPTNPC1ALDH1A1HPGD
SCHEMBL6868263 0.85 MAPT (0.46) ADORA2ANAMPTNPC1ALDH1A1RAB9A
SCHEMBL6868324 0.83 NAMPT (0.46) ADORA2ANAMPTALDH1A1HPGDKDM4E
SCHEMBL7703259 0.81 ALDH1A1 (0.42) ADORA2ANAMPTNPC1ALDH1A1HPGD
SCHEMBL6871320 0.81 SMN1; SMN2 (0.43) ALOX15ADORA2ANAMPTNPC1ALDH1A1
SCHEMBL6869779 0.80 ADORA2A (0.46) ADORA2ANAMPTALDH1A1HPGDSMN1; SMN2
SCHEMBL6868261 0.80 NPC1 (0.48) ADORA2ANPC1ALDH1A1HPGDRAB9A
SCHEMBL6870681 0.79 ADORA2A (0.49) ADORA2ANPC1ALDH1A1HPGDRAB9A
SCHEMBL6867096 0.78 TP53 (0.44) ALDH1A1HPGDSMN1; SMN2KDM4EGAA
SCHEMBL6867473 0.78 KMT2A (0.43) ADORA2ANAMPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506772-B1 Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. HOFFMANN-LA ROCHE INC. 2003-01-14 US disclosed